Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.14 USD | +2.26% | +4.65% | +9.18% |
Apr. 01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
Apr. 01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.18% | 982M | |
+33.23% | 704B | |
+28.59% | 577B | |
-3.87% | 348B | |
+18.30% | 327B | |
+5.45% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.87% | 147B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Sector Update: Health Care Stocks Mixed in Wednesday Afternoon Trading